Elisabete Couto scite author profile

Background: The FLOT4 clinical trial showed the overall survival benefit of the triplet FLOT (5-FU, oxaliplatin and docetaxel), as compared to the standard ECF scheme (epirubicin, cisplatin, 5-FU), which led to its adoption as the gold standard perioperative treatment for locally advanced, resectable, gastric tumors. This work aims to evaluate the real-life data of perioperative chemotherapy.Methods: Retrospective analysis of data from patients who received the perioperative chemotherapy regimen FLOT, from January 2018 to June 2020.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Elisabete Couto

Locally Advanced Gastric Cancer: Current and Future Strategies to Improve Outcomes with Multimodality Approach

Study of Association of Smad7 Single Nucleotide Polymorphisms with Risk and Prognosis of Colorectal Cancer in a Portuguese Population

P-207 FLOT in clinical practice: Retrospective analysis of an oncological center

Contact Info

Product

Resources

About